Dr Reddys Laboratories RDY
NYSE RDY
$12.25 +0.01 (+0.08%)
At close: Oct 2, 2026 · 4:00 PM EDT

Dr Reddys Laboratories (RDY) Net Preferred Shares Issued and Repurchased (2019 - 2026)

Updated

Dr Reddys Laboratories (RDY) reported Net Preferred Shares Issued and Repurchased of $2.62 million for the quarter ended Jun 30, 2026, up 14.4% from $2.29 million a year earlier.

Analysis

Dr Reddys Laboratories (RDY) Net Preferred Shares Issued and Repurchased (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Dr Reddys Laboratories' Net Preferred Shares Issued and Repurchased came in at $7.61 million, up 67.7% year-over-year; for the year ended Mar 31, 2026, it was $4 million, up 100.0% from the prior year.

  • Net Preferred Shares Issued and Repurchased has a five-year compound annual growth rate of 0.0% (years ended Mar 2021 to Mar 2026).
  • By year, Net Preferred Shares Issued and Repurchased came in at $2 million in the year ended Mar 31, 2025 (-80.0%), $10 million in the year ended Mar 31, 2024 (+400.0%), $2 million in the year ended Mar 31, 2023 (-50.0%) and $4 million in the year ended Mar 31, 2022 (unchanged).
  • The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Net Preferred Shares Issued and Repurchased since the quarter ended Sep 30, 2023.
  • Year over year, Net Preferred Shares Issued and Repurchased gained in two of the last four quarters, with growth averaging 200.9%.
  • The high point for year-over-year Net Preferred Shares Issued and Repurchased in five years was the quarter ended Jun 30, 2025 (growth of 905.5%); the low point was the quarter ended Dec 31, 2023 (a decline of 89.0%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Dr Reddys Laboratories 10.22 Bn 9.41 Bn 396.53 Mn 2.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.62 Mn
Sep 30, 2025 1.05 Mn
Jun 30, 2025 2.29 Mn
Sep 30, 2024 1.65 Mn
Jun 30, 2024 227,766.49
Mar 31, 2024 373,288.03
Dec 31, 2023 108,089.07
Sep 30, 2023 8.30 Mn
Jun 30, 2023 961,561.37
Mar 31, 2023 121,648.52
Dec 31, 2022 986,574.04
Sep 30, 2022 438,996.75
Jun 30, 2022 402,021.49
Mar 31, 2022 106,392.59
Dec 31, 2021 600,596.85
Sep 30, 2021 1.81 Mn
Jun 30, 2021 1.99 Mn
Mar 31, 2021 274,297.52
Dec 31, 2020 974,844.50
Sep 30, 2020 1.14 Mn
API Access

Dr Reddys Laboratories Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=RDY&period=max&api_key=YOUR_API_KEY